CLINICAL RELEVANCE: DRUG–DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS, AND TOXICITY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 846

448. Studenberg SD, Brouwer KL. 1992. Impaired biliary excretion of acetaminophen
glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in
vivo phenobarbital pretreatment. J Pharmacol Exp Ther 261: 1022-1027.
449. Sandusky GE, Mintze KS, Pratt SE, Dantzig AH. 2002. Expression of multidrug
resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using
tissue microarrays. Histopathology 41: 65-74.
450. Lee YMA, Cui Y, K onig J, Risch A, Jager B, Drings P, Bartsch H, Keppler D, Nies AT.
2004. Indentification and functional characterization of the natural vairant MRP3-Arg 1297
His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 14:
213-223.
451. Lang T, Hitzl M, Burk O, Mornhinweg E, Keil A, Kerb R, Klein K, Zanger UM,
Eichelbaum M, Fromm MF. 2004. Genetic polymorphisms in the multidrug resistance-
associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein
expression in human liver. Pharmacogenetics 14: 155-164.
452. Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P. 2001. Characterization of drug transport
by the human multidrug resistance protein 3 (ABCC3). J Biol Chem 276: 46400-46407.
453. Hirohashi T, Suzuki H, Sugiyama Y. 1999. Characterization of the transport properties
of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274:
15181-15185.
454. Zeng H, Liu G, Rea PA, Kruh GD. 2000. Transport of amphipathic anions by human
multidrug resistance protein 3. Cancer Res 60: 4779-4784.
455. Paumi CM, Wright M, Townsend AJ, Morrow CS. 2003. Multidrug resistance protein
(MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone
prostaglandin, 15-deoxy-delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
Biochemistry 42: 5429-5437.
456. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. 2000. ATP-dependent transport of
bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275:
2905-2910.
457. Zelcer N, Saeki T, Bot I, Kuil A, Borst P. 2003. Transport of bile acids in multidrug-
resistance-protein 3-overexpressing cells co-transfected with the ileal Na + -dependent
bile-acid transporter. Biochem J 369(Pt 1): 23-30.
458. Zelcer N, Wetering KV, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly Th, Dahan
A, Beijnen JH, Borst P. 2005. Mice lacking multidrug resistance protein 3 show altered
morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl
Acad SciUSA102: 7274-7279.
459. Zelcer N, Wetering KV, Waart RD, Scheffer GL, Marschall HU, Wielinga PR, Kuil A,
Kunne C, Smith A, Valk MV, et al. 2006. Mice lacking Mrp3 (Abcc3) have normal bile
salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol 44:
768-775.
460. Hitzl M, Klein K, Zanger UM, Fritz P, N ussler AK, Neuhaus P, Fromm MF. 2003.
Influence of omeprazole on multidrug reistance protein 3 expression in human liver.
J Pharmacol Exp Ther 304: 524-530.
461. Stockel B, K onig J, Nies AT, Cui Y, Brom M, Keppler D. 2000. Characterization of
the 5 -flanking region of the human multidrug resistance protein 2 (MRP2) gene and
its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. Eur J
Biochem 267: 1347-1358.